Stephen J. Tulipano
2015 - Aldeyra Therapeutics
In 2015, Stephen J. Tulipano earned a total compensation of $515K as Chief Financial Officer at Aldeyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $94,050 |
|---|---|
| Option Awards | $146,676 |
| Salary | $274,270 |
| Total | $514,996 |
Tulipano received $274.3K in salary, accounting for 53% of the total pay in 2015.
Tulipano also received $94.1K in non-equity incentive plan and $146.7K in option awards.
Rankings
In 2015, Stephen J. Tulipano's compensation ranked 10,706th out of 13,638 executives tracked by ExecPay. In other words, Tulipano earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,706 out of 13,638 | 22nd |
Division Manufacturing | 4,080 out of 5,187 | 21st |
Major group Chemicals And Allied Products | 1,499 out of 1,857 | 19th |
Industry group Drugs | 1,237 out of 1,531 | 19th |
Industry Pharmaceutical Preparations | 964 out of 1,179 | 18th |
Source: SEC filing on April 24, 2017.
Tulipano's colleagues
We found two more compensation records of executives who worked with Stephen J. Tulipano at Aldeyra Therapeutics in 2015.